¶ DNA Damage and Repair in Neurodegeneration
Dna Damage And Repair In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes [1].
DNA damage and impaired DNA repair are increasingly recognized as fundamental contributors to the pathogenesis of neurodegenerative diseases, including [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--, [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--, [ALS[/diseases/[als[/diseases/[als[/diseases/[als--TEMP--/diseases)--FIX--, and [Huntington's disease[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway--TEMP--/mechanisms)--FIX--. The brain is particularly vulnerable to DNA damage due to its exceptionally high metabolic rate (consuming ~20% of total body oxygen), the post-mitotic nature of [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- that prevents dilution of damage through cell division, and limited reliance on certain repair pathways (Madabhushi et al., 2014) [2].
Accumulating evidence indicates that DNA damage may be one of the earliest pathological events in neurodegeneration — appearing before protein aggregation, [neuroinflammation[/mechanisms/[neuroinflammation[/mechanisms/[neuroinflammation[/mechanisms/[neuroinflammation--TEMP--/mechanisms)--FIX--, or clinical symptoms. Conversely, rare hereditary DNA repair deficiency syndromes such as [ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia--TEMP--/diseases)--FIX-- and xeroderma pigmentosum provide direct proof that defective DNA repair causes neurodegeneration (McKinnon, 2009). Understanding the interplay between DNA damage, repair, and neuronal survival opens new therapeutic avenues for age-related neurodegenerative conditions [3].
The brain's high oxygen consumption generates substantial [reactive oxygen species[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress--TEMP--/mechanisms)--FIX-- ([ROS[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress--TEMP--/mechanisms)--FIX-- as byproducts of [mitochondrial] electron transport. [ROS[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress--TEMP--/mechanisms)--FIX-- produce more than 100 different oxidative base modifications in DNA, the most common being 8-oxoguanine (8-oxoG), thymine glycol, and 5-hydroxycytosine (Lindahl, 1993). It is estimated that each neuron sustains approximately 10,000–100,000 oxidative DNA lesions per day (Ames et al., 1993) [4].
Sources of oxidative damage include:
- Mitochondrial respiration: The electron transport chain is the primary endogenous source of superoxide (O₂⁻) and hydrogen peroxide (H₂O₂)
- [neuroinflammation[/mechanisms/[neuroinflammation[/mechanisms/[neuroinflammation[/mechanisms/[neuroinflammation--TEMP--/mechanisms)--FIX--: Activated [microglia
Recent work has revealed that some DNA damage in [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- is not merely pathological but serves physiological functions:
- Activity-dependent DSBs: Neuronal stimulation induces DSBs at specific genomic loci to facilitate expression of immediate-early genes critical for [long-term potentiation[/entities/[long-term-potentiation[/entities/[long-term-potentiation[/entities/[long-term-potentiation--TEMP--/entities)--FIX-- and memory formation (Madabhushi et al., 2015)
- Enhancer activation: DNA breaks at enhancer elements regulate gene expression programs essential for neuronal plasticity
- Epigenetic remodeling: [DNA methylation[/entities/[dna-methylation[/entities/[dna-methylation[/entities/[dna-methylation--TEMP--/entities)--FIX-- and [histone modification] changes at damage sites influence chromatin state
This dual nature of DNA damage — as both pathological threat and physiological signal — makes neuronal genome maintenance particularly complex [5].
BER is the primary pathway for repairing oxidative DNA damage and SSBs in the brain. It involves:
- Damage recognition: DNA glycosylases (OGG1, NEIL1, NEIL2, NTH1) recognize and excise damaged bases
- AP site processing: AP endonuclease 1 (APE1) cleaves the DNA backbone
- Gap filling: DNA polymerase β (Polβ) fills the gap
- Ligation: DNA ligase III/XRCC1 complex seals the nick
BER is critical in both nuclear and [mitochondrial] DNA repair. Defective BER has been documented in:
- [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--: Reduced Polβ and OGG1 activity in AD brains; decreased BER capacity in mild cognitive impairment (MCI) suggests this is an early event (Weissman et al., 2007)
- [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--: Elevated mitochondrial OGG1 in the [substantia nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra--TEMP--/brain-regions)--FIX--; decreased APE1 expression correlates with dopaminergic neuron loss
- ALS: Reduced APE1 expression and activity in motor [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- (Kisby et al., 1997)
NER repairs bulky DNA adducts and helix-distorting lesions. Two sub-pathways exist:
- Global genome NER (GG-NER): Surveys the entire genome; deficiency causes xeroderma pigmentosum (XP), associated with skin cancer and variable neurodegeneration
- Transcription-coupled NER (TC-NER): Repairs damage in actively transcribed genes; deficiency causes Cockayne syndrome (CS) and trichothiodystrophy (TTD), both characterized by severe progressive neurodegeneration (Cleaver et al., 2009)
NER deficiency syndromes demonstrate that post-mitotic [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- are uniquely vulnerable to transcription-blocking DNA lesions, which cannot be bypassed through replication-based tolerance mechanisms [6].
¶ Double-Strand Break Repair
[neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- primarily rely on two pathways for DSB repair:
Non-Homologous End Joining (NHEJ)
The dominant DSB repair pathway in post-mitotic [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--, since homologous recombination requires a sister chromatid template available only during S/G2 phase. Key components include:
- DNA-PKcs (DNA-dependent protein kinase, catalytic subunit)
- Ku70/Ku80 heterodimer
- XRCC4/DNA Ligase IV complex
NHEJ activity declines with aging and is reduced in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- brains (Shackelford, 2006) [7].
Homologous Recombination (HR)
Although [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- are post-mitotic, limited HR activity has been detected, possibly using the homologous chromosome as template. Components include BRCA1, BRCA2, and RAD51 (Welty et al., 2018).
The master kinases ATM (ataxia-telangiectasia mutated) and ATR (ATM- and Rad3-related) coordinate the DNA damage response (DDR):
- ATM: Activated by DSBs; phosphorylates >700 substrates including H2AX, p53, BRCA1, CHK2. [Loss causes [ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia--TEMP--/diseases)--FIX--, characterized by progressive cerebellar neurodegeneration (Shiloh, 2003)
- ATR: Activated by SSBs and stalled replication forks; mutations cause Seckel syndrome with microcephaly
- Downstream signaling: p53 activation, cell cycle checkpoint engagement, and (in irreparable damage) activation of [apoptotic] or senescence programs
In [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--, ATM serves additional functions beyond canonical DDR, including regulation of [autophagy[/entities/[autophagy[/entities/[autophagy[/entities/[autophagy--TEMP--/entities)--FIX--, vesicle trafficking, synaptic function, and [mitochondrial] homeostasis (Choy & Bhatt, 2018) [8].
DNA damage is prominently elevated in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--:
- Oxidative DNA damage: 8-oxoG levels are increased 2–3 fold in AD brain regions, particularly [hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus--TEMP--/brain-regions)--FIX-- and [entorhinal [cortex[/brain-regions/[cortex[/brain-regions/[cortex[/brain-regions/[cortex--TEMP--/brain-regions)--FIX-- (Wang et al., 2005)
- DSBs: Elevated γH2AX foci (a DSB marker) in AD [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--; increased DSBs observed in mild cognitive impairment (MCI), indicating early involvement
- [Amyloid-β[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- and DNA damage: [Aβ[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- oligomers induce oxidative DNA damage and impair DNA repair; [Aβ[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- may directly interact with DNA repair proteins
- [Tau[/entities/[tau-protein[/entities/[tau-protein[/entities/[tau-protein--TEMP--/entities)--FIX-- and DDR: Pathological tau] depletes nuclear BRCA1, impairing DSB repair and genome stability (Violet et al., 2014)
- BER deficiency: Reduced Polβ, OGG1, and APE1 activity in AD brains (Weissman et al., 2007)
- [Epigenetic] consequences: DNA damage at gene promoters can alter [DNA methylation[/entities/[dna-methylation[/entities/[dna-methylation[/entities/[dna-methylation--TEMP--/entities)--FIX-- patterns and [histone modifications[/entities/[histone-modifications[/entities/[histone-modifications[/entities/[histone-modifications--TEMP--/entities)--FIX--, contributing to gene expression changes in AD
- Mitochondrial DNA damage: [Mitochondrial DNA] is especially vulnerable due to proximity to the electron transport chain and limited repair capacity; mtDNA deletions accumulate in [substantia nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra--TEMP--/brain-regions)--FIX-- [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--
- [α-synuclein[/proteins/[alpha-synuclein[/proteins/[alpha-synuclein[/proteins/[alpha-synuclein--TEMP--/proteins)--FIX-- and DNA damage: α-Synuclein accumulation impairs DSB signaling and reduces recruitment of repair factors to damage sites (Schaser et al., 2019)
- [LRRK2[/genes/[lrrk2[/genes/[lrrk2[/genes/[lrrk2--TEMP--/genes)--FIX-- and DDR: LRRK2, the most commonly mutated gene in familial PD, plays a role in DNA damage sensing and repair
- [PINK1[/genes/[pink1[/genes/[pink1[/genes/[pink1--TEMP--/genes)--FIX--/[Parkin[/genes/[prkn[/genes/[prkn[/genes/[prkn--TEMP--/genes)--FIX--: These mitophagy regulators also influence nuclear genome stability through removal of damaged mitochondria that produce excess [ROS[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress--TEMP--/mechanisms)--FIX--
- Dopamine-induced damage: Dopamine oxidation generates DNA-damaging quinones and [ROS[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress--TEMP--/mechanisms)--FIX--, contributing to selective vulnerability of dopaminergic [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--
- [TDP-43[/entities/[tdp-43[/entities/[tdp-43[/entities/[tdp-43--TEMP--/entities)--FIX-- and DDR: [TDP-43[/entities/[tdp-43[/entities/[tdp-43[/entities/[tdp-43--TEMP--/entities)--FIX-- is recruited to DSB sites and facilitates NHEJ; its cytoplasmic mislocalization in ALS/[FTD[/diseases/[ftd[/diseases/[ftd[/diseases/[ftd--TEMP--/diseases)--FIX-- impairs DSB repair (Mitra et al., 2019)
- [FUS[/entities/[fus[/entities/[fus[/entities/[fus--TEMP--/entities)--FIX-- and DNA repair: FUS protein participates in DSB repair through its interaction with HDAC1 and XRCC1; ALS-associated FUS mutations impair DNA ligation (Wang et al., 2013)
- [C9orf72[/genes/[c9orf72[/genes/[c9orf72[/genes/[c9orf72--TEMP--/genes)--FIX-- repeat expansions: Generate R-loops (DNA-RNA hybrids) that stall transcription and cause DNA damage; also sequester DNA repair factors
- [SOD1[/proteins/[sod1-protein[/proteins/[sod1-protein[/proteins/[sod1-protein--TEMP--/proteins)--FIX-- mutations: Mutant SOD1 increases oxidative DNA damage in motor [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--
- Somatic repeat expansion: The CAG repeat in the [huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin--TEMP--/proteins)--FIX-- gene undergoes somatic expansion, driven by mismatch repair (MMR) pathway components (particularly MSH3); this expansion correlates with disease onset and progression (Genetic Modifiers of HD Consortium, 2019)
- Oxidative DNA damage: Elevated 8-oxoG in [Huntington's disease[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway--TEMP--/mechanisms)--FIX-- brain
- BER involvement: OGG1-initiated BER of oxidized CAG repeats may paradoxically promote repeat expansion through a "toxic oxidation cycle" (Kovtun et al., 2007)
- Therapeutic target: Inhibition of MSH3 or other MMR components to prevent somatic expansion is a major therapeutic strategy under investigation
Several Mendelian disorders directly link defective DNA repair to neurodegeneration:
| Syndrome |
Gene(s) |
Repair Pathway |
Neurological Features |
| [Ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia--TEMP--/diseases)--FIX-- |
ATM |
DSB signaling |
Progressive cerebellar ataxia, oculomotor apraxia |
| Cockayne syndrome |
CSA, CSB |
TC-NER |
Microcephaly, demyelination, [cerebellum[/brain-regions/[cerebellum[/brain-regions/[cerebellum[/brain-regions/[cerebellum--TEMP--/brain-regions)--FIX-- atrophy |
| Xeroderma pigmentosum |
XPA-XPG |
NER |
Variable neurodegeneration, sensorineural deafness |
| AOA1 (ataxia with oculomotor apraxia 1) |
APTX |
SSB repair |
Cerebellar ataxia |
| SCAN1 |
TDP1 |
SSB/topoisomerase repair |
Cerebellar ataxia |
| [Friedreich's Ataxia[/diseases/[friedreichs-ataxia[/diseases/[friedreichs-ataxia[/diseases/[friedreichs-ataxia--TEMP--/diseases)--FIX-- |
FXN |
Oxidative damage tolerance |
Progressive sensory/cerebellar ataxia |
- NAD+ supplementation: NAD+ is consumed by PARP1 during SSB repair; declining NAD+ levels with aging impair DNA repair. Supplementation with nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) may restore repair capacity (Fang et al., 2017)
- PARP inhibitors: Paradoxically, while PARP1 aids repair, its hyperactivation depletes NAD+ and triggers [parthanatos[/mechanisms/[parthanatos[/mechanisms/[parthanatos[/mechanisms/[parthanatos--TEMP--/mechanisms)--FIX-- (a form of cell death); PARP inhibition may protect [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX-- from energy depletion
- ATM/ATR modulators: Small molecules that enhance DDR signaling under investigation for neuroprotection
For [Huntington's disease[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway--TEMP--/mechanisms)--FIX-- and other trinucleotide repeat disorders:
- MSH3 inhibition: Reducing mismatch repair-driven somatic expansion
- MSH3 antisense oligonucleotides: In preclinical development
- Small molecule MMR modulators: Under investigation
Reducing oxidative DNA damage through:
- Mitochondria-targeted antioxidants: MitoQ, SS-31 (elamipretide)
- NRF2 activation: Enhancing endogenous antioxidant defense genes
- [ferroptosis[/mechanisms/[ferroptosis[/mechanisms/[ferroptosis[/mechanisms/[ferroptosis--TEMP--/mechanisms)--FIX-- inhibitors: Preventing iron-dependent lipid peroxidation and associated DNA damage
- Gene replacement therapy for specific DNA repair deficiencies (e.g., ATM, CSB) is under preclinical investigation
- AAV-mediated gene delivery to the CNS shows promise in animal models of [ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia[/diseases/[ataxia-telangiectasia--TEMP--/diseases)--FIX--
- [Huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin--TEMP--/proteins)--FIX--
- [All Mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/mechanisms
The study of Dna Damage And Repair In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development [9].
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions [10].
- [Madabhushi R, Pan L, Tsai LH (2014]. DNA damage and its links to neurodegeneration. [Neuron[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--. 83(2):266-282. DOI
- [McKinnon PJ (2009]. DNA repair deficiency and neurological disease. Nat Rev Neurosci. 10(2):100-112. DOI
- [Lindahl T (1993]. Instability and decay of the primary structure of DNA. Nature. 362(6422):709-715. DOI
- [Ames BN, Shigenaga MK, Hagen TM (1993]. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 90(17):7915-7922. DOI
- [Suberbielle E, Sanchez PE, Kravitz AV, et al. (2013]. Physiologic brain activity causes DNA double-strand breaks in [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--. Nat Neurosci. 16(9):1693-1700. DOI
- [Madabhushi R, Gao F, Pfenning AR, et al. (2015]. Activity-induced DNA breaks govern the expression of neuronal early-response genes. Cell. 161(7):1592-1605. DOI
- [Weissman L, Jo DG, Sørensen MM, et al. (2007]. Defective DNA base excision repair in brain from individuals with [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- and amnestic mild cognitive impairment. Nucleic Acids Res. 35(16):5545-5555. DOI
- [Cleaver JE, Lam ET, Revet I (2009]. Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet. 10(11):756-768. DOI
- [Shiloh Y (2003]. ATM and related protein kinases. Nat Rev Cancer. 3(3):155-168. DOI
- [Choy KR, Bhatt DL (2018]. Neurodegeneration in ataxia-telangiectasia: multiple roles of ATM kinase in cellular homeostasis. Dev Dyn. 247(1):33-46. DOI
- [Wang J, Xiong S, Xie C, et al. (2005]. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's Disease. J Neurochem. 93(4):953-962. DOI
- [Violet M, Delattre L, Tardivel M, et al. (2014]. A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions. Front Cell Neurosci. 8:84. DOI
- [Schaser AJ, Osterberg VR, Dent SE, et al. (2019]. [alpha-synuclein[/mechanisms/[alpha-synuclein[/mechanisms/[alpha-synuclein[/mechanisms/[alpha-synuclein--TEMP--/mechanisms)--FIX-- is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci Rep. 9(1):10919. DOI
- [Wang WY, Pan L, Su SC, et al. (2013]. Interaction of FUS and HDAC1 regulates DNA damage response and repair in [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--. Nat Neurosci. 16(10):1383-1391. DOI
- [Genetic Modifiers of Huntington's Disease Consortium (2019]. CAG repeat not polyglutamine length determines timing of Huntington's Disease onset. Cell. 178(4):887-900. DOI
- [Kovtun IV, Liu Y, Bjoras M, et al. (2007]. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature. 447(7143):447-452. DOI
- [Fang EF, Kassahun H, Croteau DL, et al. (2016]. NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24(4):566-581. DOI
- [Shackelford DA (2006]. DNA end joining activity is reduced in Alzheimer's Disease. Neurobiol Aging. 27(4):596-605. DOI
- [Kisby GE, Milne J, Sweatt C (1997]. Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. Neuroreport. 8(6):1337-1340. DOI
🟡 Moderate Confidence
| Dimension |
Score |
| Supporting Studies |
19 references |
| Replication |
33% |
| Effect Sizes |
25% |
| Contradicting Evidence |
33% |
| Mechanistic Completeness |
50% |
Overall Confidence: 52%